Related by context. All words. (Click for frequent words.) 68 indication 65 Indications 51 indicating 51 Early indications 49 unconfirmed reports 49 evidence 48 targeting refractory relapsing 48 indicated 47 signs 47 indicate 44 anecdotal evidence 44 PulmoScience believes 44 indicators 44 remitting Multiple Sclerosis 43 reports 43 indicates 43 Preliminary indications 43 telltale signs 42 Initial indications 42 outward signs 42 complement Coblation within 42 Bracketed figures 41 candidates Dyloject TM 41 oral hyoscyamine spray 41 plausible explanations 40 Nicole Onetto MD 40 motesanib 40 Entereg R 40 assurances 40 inklings 40 suggesting 40 indictors 40 AVERROES 40 hints 40 Aplidin 39 Ceflatonin 39 conclusive evidence 39 rumblings 39 COLAL PRED 39 hoax Alderden 39 suggest 39 macitentan 39 ruxolitinib 39 spokesman Fred Opolot 39 Exelixis compounds 39 powerful Israelite kingdom 39 reassurances 38 possibility 38 solanezumab 38 RRMS patients 38 cannabinor 38 Oncogenex 38 AMPK activators 38 MyVax personalized immunotherapy 38 KIACTA ™ 38 signals 38 portents 38 gepirone ER 38 PROSTVAC TM 38 commercially exploitable mineralization 38 ASONEP 38 Restanza demonstrated 38 Zarar Ahmad Muqbal 38 inflexibility Rimmer 38 subgroup analyzes 38 myeloproliferative neoplasms MPNs 38 investigating Serdaxin 38 Phase IIa clinical trials 38 anger Adlerstein 38 preclinical models 38 riociguat 38 irrefutable proof 38 TroVax ® 38 better childproof containers 38 incyclinide 37 conflicting signals 37 severe hypersensitivity reactions 37 Aurexis 37 Vojo Vukovic MD Ph.D. 37 Fanconi syndrome 37 BNC# 37 hematological indications 37 Mechanistic studies 37 samalizumab 37 secondary efficacy endpoints 37 CTLA4 Ig product 37 #D#C# 37 appears 37 OvaRex R 37 Augment Injectable 37 talactoferrin 37 economist Paul Samter 37 heavily pretreated patients 37 Urocidin 37 Tarceva TM 37 Apoptone 37 ALK inhibitors 37 rALLy trial 37 considerable dismay Salord 37 pilot radioed mayday 37 irrefutable evidence 36 patriotism Gration 36 non selective NSAIDs 36 confirmed 36 likelihood 36 warnings 36 Alzheimer disease psychosis 36 murmurings 36 elevated creatine phosphokinase 36 Reversible Posterior Leukoencephalopathy Syndrome 36 CA4P 36 amrubicin 36 pharmacological therapies 36 CDK inhibitors 36 oral picoplatin 36 Recoverable PGM ounces 36 incontrovertible evidence 36 tramiprosate Alzhemed TM 36 oxypurinol 36 bapineuzumab 36 elacytarabine 36 there 36 neratinib 36 toxicological tests 36 alvespimycin 36 Liposomal Grb 2 36 hint 36 GED aPC 36 DACH platinum 36 efficacy endpoints 36 nonclinical studies 36 Akt inhibitor 36 denosumab oncology 36 Evoltra TM 36 phase Ib 36 Ganetespib 36 intravenous bisphosphonate therapy 36 antiangiogenic activity 36 Phase IIB clinical 36 TOLAMBA 36 molecular imaging radiopharmaceuticals 36 Antioxidant supplements 36 elevated creatinine phosphokinase 36 AML acute myeloid 36 TLR8 agonist 36 Budesonide foam crofelemer 36 prognostic biomarkers 36 Downside risks 36 proof 36 standoff Stacho 36 Bapineuzumab 36 forodesine hydrochloride BCX 36 definite 36 clues 36 apremilast 36 Zavesca r 36 adjuvanted flu 36 Indication 36 MCSP respectively 36 Rhucin R 36 MediGene focuses 36 clinically meaningful differences 36 registrational 36 VEGF inhibitors 36 initiate Phase 2b 36 pharmacokinetic studies 35 GALNS 35 generation URAT1 inhibitor 35 MMP inhibitors 35 nonprescription NSAIDs 35 Behcet uveitis 35 Tracleer r 35 dexanabinol 35 Phase 2a 35 vaccination Schuchat 35 heavily pretreated 35 ie antibody mediated 35 studies evaluating satraplatin 35 tantalizing hint 35 Zoraxel 35 Subgroup analyzes 35 neuropsychiatric adverse 35 tolerability profiles 35 cortical stimulation therapy 35 Andrin Oswald CEO 35 hematologic cancers 35 Phase IIa trial 35 cautiously optimistic 35 acute HAE attacks 35 mGluR5 NAM 35 hematological cancers 35 sideway trading 35 follicular Non Hodgkin 35 asthma immunotherapeutic 35 vaginal lidocaine 35 IIa trials 35 misused Teuber added 35 mg/m2 cohort 35 oral prodrug 35 class mGluR5 inhibitor 35 injectable depot 35 generation proteasome inhibitor 35 inkling 35 observation Miramontez 35 dose limiting toxicities 35 stent thromboses 35 overlapping toxicities 35 preclinically 35 barring unforeseen circumstances 35 romidepsin 35 Steffen fingertip got 35 Virulizin ® 35 genomic biomarkers 35 Fresher barometers however 35 TNF blocker therapy 35 NSABP C 35 myoglobinuria rhabdomyolysis 35 elotuzumab 35 conclusive proof 35 andthere 35 adipiplon 35 anecdotal evidence suggests 35 fusion enhancers 35 Conclusive evidence 35 ASA# 35 Dr. Pazdur 35 buoying sentiment 35 midstage clinical trials 35 Satraplatin 35 Pazopanib 35 Zemiva TM 35 mom anymore Veraflor 35 huC# DM4 35 PI3 kinase inhibitors 35 Zybrestat 35 neuropsychiatric symptoms 35 immunotherapeutic approaches 35 iclaprim 35 ocular formulation 35 Rifamycin SV MMX 35 PS# DARA 35 MKC# PP 35 rBChE 35 aberration Wexler 35 confirmation 35 BrachySil 35 S/GSK# 35 prima facie evidence 35 gemifloxacin 35 tonabersat 35 coincident anomalies 35 bioabsorbable stent 35 BCR ABL mutation 35 CSL Behring therapies 35 isavuconazole 35 hematological tumors 35 NP2 Enkephalin 35 hereditary deficiency 35 H#N# adjuvanted vaccine 35 efficacy endpoint 35 rALLy 35 Anecdotal reports 35 adjuvant colon cancer 35 AQUAVAN R 35 embed Lapan 35 LHRH analogues 35 TOCOSOL Camptothecin 35 blood clot dissolving 35 Bughaigis 35 hopeful 35 CR# vcMMAE 35 cediranib 35 Folotyn 35 parkinsonian symptoms 35 Evidence 35 Darinaparsin 34 lorvotuzumab mertansine 34 Memryte 34 taxane resistant 34 induced tumor regression 34 multitargeted 34 TNF alpha inhibitors 34 SOM# 34 Azixa MPC 34 K ras mutations 34 anti angiogenic agents 34 COMT inhibitors 34 Unconfirmed dispatch 34 evidences 34 ularitide 34 Serdolect 34 tubulin inhibitor 34 Fast Track designations 34 Gleevec Glivec 34 cetuximab Erbitux 34 ENSO neutral 34 armyworm outbreaks 34 bardoxolone methyl 34 fostamatinib disodium 34 GRN# 34 rindopepimut 34 induced suicidality 34 PLX cells 34 OXi# 34 Phenoptin 34 Benlysta belimumab 34 JAK#/JAK# inhibitor 34 vascular disrupting agent 34 PRIMO CABG 34 confirming 34 indiplon capsules 34 unconfirmed 34 MGN# 34 vinflunine 34 nalbuphine ER 34 Cotara 34 rEV# 34 believed 34 Mevacor OTC 34 VELCADE novel 34 dysfunction Zada 34 PROCHYMAL 34 biochemical abnormalities 34 thrombolytic agents 34 bavituximab monotherapy trial 34 conflicting accounts 34 RSD# oral 34 Elevated PSA 34 rheumatoid arthritis psoriatic arthritis 34 PRT# 34 glioblastoma tumors 34 Azixa 34 refractory Hodgkin 34 Serdaxin 34 convalescing Fidel Castro 34 Phenserine 34 ANCHOR trial 34 lipid lowering therapies 34 ostarine 34 Xience V stent 34 Pantginis 34 nucleoside analogs 34 ICA # 34 ProLindac 34 inhaled iloprost 34 MGCD# clinical trials 34 iroxanadine 34 ponatinib 34 phase IIb study 34 factor TNF 34 Geoff Meacham 34 JAK#/JAK# inhibitor CYT# 34 pervasive weariness 34 daily bactericidal antibiotic 34 pulmonary toxicity 34 antemortem 34 canagliflozin 34 abating 34 jitteriness 34 DGAT1 inhibitors 34 supratherapeutic doses 34 bifeprunox 34 Oglemilast 34 Campath ® 34 Tyzeka Sebivo 34 Bioenvision compounds under 34 signaled 34 LymphoStat B 34 signaling 34 Phase 2b clinical trials 34 IIa trial 34 urocortin 2 34 Pharmos pipeline 34 gastrointestinal mucositis 34 Phase 2a trial 34 Gaboxadol 34 Betaferon Betaseron 34 calcineurin inhibitors 34 CYT# 34 imexon 34 Vitaxin 34 fampridine SR 34 RH1 34 Gattex 34 PROVIGIL 34 hypoxia activated prodrug 34 MyVax 34 initiate Phase IIb 34 statistically significant correlations 34 Incoming barometers continue 34 Troxatyl 34 p# inhibitor 34 BRAF V# mutation 34 Fibrillex 34 Triolex 34 probing Nozette 34 Somatuline Autogel 34 EMPOWER Study 34 uridine triacetate 34 CINOD 34 categorical denials 34 tecarfarin 34 Mesafem 34 struggles Bahamonde 34 Orphan Drug status 34 causal relation 34 forodesine HCl 34 acknowleded 34 rhC1INH 34 OMAPRO 34 Phase Ib study 34 indictor 34 KNS # 34 midstage studies 34 ragweed allergy immunotherapeutic 34 hematologic cytogenetic 34 Plenaxis R 34 presumed 34 confirm 34 vosaroxin 34 skeletal metastases 34 CytoFabTM 34 oral PTH 34 Slightly Oversold 34 cognitive impairment associated 34 Spokesman Zemeri Bashary 34 investigational therapies 34 uh ruh 33 told BioWorld Today 33 AZX# 33 bosutinib 33 RoACTEMRA 33 fruit flavored meads 33 CDP# 33 adjuvanted vaccines 33 conclusive 33 olanzapine LAI 33 PRECISE Trial 33 TNF blocking 33 secondary endpoints 33 aerosol metered dose 33 pandemic influenza strains 33 Van Esveld 33 hematologic tumors 33 Troxatyl TM 33 PNH patients 33 CytoFab ™ 33 enzastaurin 33 Reclast Aclasta 33 SMT C# 33 phase 2a 33 anti EGFR antibody 33 preliminary 33 midstage study 33 chemopreventive agent 33 leading oral taxane 33 Christoph Weil 33 taspoglutide 33 fibrotic diseases 33 Onalta ™ 33 disavowals 33 pharmacological interventions 33 urate lowering 33 Trofex TM 33 Arsenic trioxide 33 options.Past performance 33 guardedly optimistic 33 omega interferon 33 cefixime 33 antiangiogenic drugs 33 squalamine 33 pharmacodynamic markers 33 Protamine 33 preclinical studies 33 Significant Spacecraft Anomalies 33 coagulation disorders 33 Prestara 33 Xuebin Zhang research 33 Toxicological tests 33 nitric oxide depletion 33 definites 33 Asentar 33 locoregional recurrence 33 Preclinical studies suggest 33 CELVAPAN H#N# 33 Optiquel ™ 33 arbaclofen 33 MEK inhibitors 33 Syndrome RLS 33 Shigamabs ® 33 AVN# [001] 33 placebo controlled clinical trials 33 Allovectin 7 ® 33 ZADAXIN 33 INDICATIONS 33 midstage clinical trial 33 lenalidomide dexamethasone 33 Evoltra ® 33 hematological toxicity 33 Sigma Tau SpA 33 lurasidone 33 Mipomersen 33 theories abound 33 ELIQUIS 33 tumor malignancies 33 TheraCIM 33 ZYBRESTAT fosbretabulin 33 psychotherapeutic interventions 33 etiological factors 33 Possible explanations 33 #.#-#.#/tonne CFR 33 genotypic resistance 33 CML CP 33 almorexant 33 taxane refractory 33 pazopanib 33 IND submission 33 PulmoBind TM 33 antineoplastic 33 drug Amevive 33 etiologic factors 33 PROSTVAC ® 33 Saphris 33 HGS ETR2 33 triphendiol 33 Bone metastases represent 33 rufinamide 33 pharmacological approaches 33 darinaparsin Zinapar TM 33 EEG abnormalities 33 AVI antisense 33 figitumumab 33 Lu AA# 33 brostallicin 33 Khushigian hunches took 33 AQ4N 33 #.#-#.#/oz 33 adulterated peanuts 33 perampanel 33 Prodarsan 33 spokeswoman Denise Taiste 33 Orphan Drug designations 33 Al Abullah 33 MACD Moving Averages 33 compound INCB# 33 multicenter clinical trials 33 dimebon latrepirdine 33 Removab 33 Provecta 33 SPARLON 33 IGF IR 33 tremelimumab 33 dose cohorts 33 Zolopa 33 Nanocort 33 cMET inhibitor 33 fidaxomicin Phase 3 33 refractory indolent NHL 33 Michael Kaplitt Parkinson 33 Prochymal 33 Lorianne Masuoka MD 33 omens 33 feelers 33 indolent NHL 33 oral anticancer 33 humanised monoclonal antibody 33 evaluating Prochymal 33 grade serous ovarian 33 cMET 33 clearest signal 33 Moats blindsided 33 signal 33 Tasigna prolongs 33 histologies 33 KRAS status 33 discomfort Sicherer 33 VDAs 33 possibilities 33 CA9 SCAN 33 Buglova 33 footwall sediments 33 MS spasticity 33 mTOR inhibition 33 budesonide foam 33 iniparib 33 Tavocept 33 ganetespib 33 GLPG# 33 severe dermatologic toxicities 33 sirtuin activators 33 imminent 33 tantalizing clues 33 PresbyLens ® 33 antiresorptive 33 Pimavanserin 33 hypersensitivity allergic reactions 33 Premarket futures 33 antidiabetic medications 33 pomalidomide 33 multiple concomitant medications 33 GLP toxicology studies 33 anticancer activity 33 TELCYTA 33 IIa clinical trial 33 AVI ESPRIT technology 33 NEUMUNE 33 newsflows 33 circulatory dysfunction 33 deceased Wolfinger 33 Fibrillex TM 33 Afatinib 33 barometers suggest 33 Carfilzomib 33 demonstrated antitumor activity 33 Nimotuzumab 33 haematological malignancies 33 HyQ 33 #.#-#.#/tonne CFR cost 33 corroboration Emery 33 NeoLipid drug 33 potent neuroprotective 33 Simdax 33 myeloproliferative diseases 33 danoprevir 33 volociximab 33 briakinumab 33 vivo coagulation 33 Phase IIb trials 33 YONDELIS R 33 cadmium poisonings associated 33 hypotheses 33 Xcytrin R 33 Rhucin ® 33 PulmoBind ™ 33 shigella diarrhea 33 DAC HYP 33 Archexin 33 oncology indications 33 Linjeta TM 33 Q#IR 33 Applied Therapeutics ENT 33 website jabil.com 33 skeletal sarcomere activator 33 Zemplar Capsules 33 metastatic sarcoma 33 KRAS mutated 33 anti angiogenic drugs 33 Xinlay 33 suggests 33 Fusilev 33 MetMAb 33 neuropathic pain nerve 33 Endeavor stent 33 therapeutic regimens 33 Vicinium TM 33 Evenly Balanced 33 actinic keratoses AKs 33 speculations 33 MAXY alpha 33 Valdoxan 33 scintigraphic 33 relapsers 33 Chris Buonanno meteorologist 33 inhibit angiogenesis 33 Neupro ® 33 cytotoxic therapies 33 Orazol 33 drillholes intersected 33 implication 33 canakinumab 33 painkiller Prexige 33 molecular biomarkers 33 preholiday intelligence 33 Andrew Gledhill 33 confirmatory 33 Neupro patch 33 ASHCROFT Well 33 PDE# inhibitors 33 cautioned 33 Hourly indicators 33 Pagoclone 33 Phase IIIb clinical 33 IMC #F# 33 regenerating bone 33 Flutiform ™ 33 QT interval prolongation 32 Plavix cautioning 32 tamibarotene 32 ovarian suppression 32 SNT MC# 32 include GALNS N 32 Alzhemed TM 32 statistically significant superiority 32 serologic tests 32 rumors circulated 32 Public Offerings IPOs 32 lung cancer NSCLC 32 acute diffuse infiltrative 32 Desmoteplase 32 pimavanserin 32 evidence implicating 32 immunological disorders 32 receptor tyrosine kinase inhibitor 32 pediatric malignancies 32 Phase III trials 32 AZILECT ® 32 FACTIVE tablets 32 generic pantoprazole 32 PXD# 32 bardoxolone 32 darbepoetin alpha 32 approve Arcoxia 32 TAXUS Liberte stent 32 EndoTAG TM 32 Firdapse 32 OvaRex ® MAb 32 pain palliation 32 Ms Buchtmann 32 VNP#M 32 novel oral anticoagulant 32 Currently Nymox 32 MAbs targeting 32 Pirfenidone 32 Phase #/#a clinical 32 Marghoob Saleem Butt 32 GEM OS2 32 circulating endothelial cells 32 axitinib 32 Relovair 32 NB S# strontium malonate 32 Alequel 32 vigorous denials 32 blood thinner apixaban 32 olaparib 32 phase IIb trial 32 diarrheal disease malaria 32 #.#-#.# oz 32 prodrome 32 Soliris TM eculizumab 32 adjuvant therapies 32 Anidulafungin 32 Silenor NDA 32 disease modifying 32 toremifene citrate 32 Telintra 32 SAR# [004] 32 Lupuzor 32 proteasome inhibitor 32 phase IIa 32 Inovio pipeline 32 paliperidone ER 32 lintuzumab SGN 32 Empirical studies 32 Colon polyps 32 Coroner Glenn Rhoad 32 zileuton 32 rheumatoid arthritis juvenile idiopathic 32 CFNAI MA3 suggests 32 triglyceride lowering 32 SYN# 32 connective tissue diseases 32 gold geochemical anomalies 32 non squamous histology 32 antiangiogenic agents 32 lumiliximab 32 Aclasta Reclast 32 tezampanel 32 galiximab 32 Millennium Velcade 32 accelerating dermal 32 cancerous mesothelioma 32 Magneceutical ® Therapy 32 CYT# vascular disrupting 32 Solasia 32 XL# XL# XL# XL# 32 Tasimelteon 32 breast cancer pill Tykerb 32 omeprazole sodium bicarbonate 32 Phase III 32 Avastin adjuvant 32 subclinical disease 32 GVAX 32 reassurance 32 Phase IIb III 32 TransVax 32 inhalation anthrax infection 32 omeprazole widely 32 Prodarsan ® 32 counterfeit Alli 32 ticagrelor Brilinta 32 PEG SN# 32 intravenous bisphosphonates 32 intimation 32 riluzole 32 viral reactivation 32 GSK3B 32 TRAIL receptor antibodies 32 ALB # 32 6R BH4 32 T DM1 32 potency waned 32 imatinib resistance 32 Orathecin 32 warning 32 arsenic trioxide ATO 32 cardiac tamponade cerebral edema 32 HuMax CD4 32 refractory acute myeloid 32 adulterated peanuts came 32 antidiabetic therapy 32 prognosis 32 clinical trials dacetuzumab SGN 32 phase IIa clinical 32 sundowner prediction 32 CRu 32 unconfirmed rumors 32 refractory CTCL 32 ozarelix 32 outwardly radicalized 32 lung pancreatic 32 Myriad Flurizan 32 POSIDUR TM 32 www.soliris.net 32 SIRT1 activators 32 intimations 32 MAGE A3 ASCI 32 Rezular 32 therapies 32 Oncophage vitespen 32 historical precedents 32 Klaus Rinnen managing 32 Xerese 32 rumors circulating 32 disinflationary trend 32 anecdotal snapshots 32 HIV associated lipodystrophy 32 Phase Ib 32 Terns nest 32 influenza subtype 32 R alvimopan 32 Seyfert galaxies 32 LE DT 32 Granisetron Hydrochloride Injection 32 pramipexole 32 clearest indication 32 transgenically produced product 32 IMA# 32 depressingly conspicuous 32 ritonavir boosted danoprevir 32 Thrombotic events 32 immune modulating 32 Severe hypersensitivity reactions 32 Phase 2b trial 32 anti leukemic 32 neuropsychiatric events 32 TBC# 32 cautious optimism 32 Vibativ 32 Additionally Nexavar 32 multikinase inhibitors 32 telomerase inhibition 32 leveraging AutEx 32 valopicitabine 32 Cimzia TM 32 gastric pancreatic 32 Conflicting reports 32 confirms 32 Selzentry Celsentri 32 nasal formulation 32 inflammation thrombosis oncology 32 Epidemiologic studies 32 Apo2L 32 HQK 32 Resolute DES 32 preexisting immunity 32 registrational trials 32 anti HBc 32 AMID Stapler TM 32 randomized discontinuation trial 32 novel trazodone formulation 32 AGGRASTAT ® tirofiban hydrochloride 32 treatmentof 32 doubt 32 estramustine 32 indicator 32 maribavir 32 BEMA TM LA 32 TransVax ™ 32 irritative 32 ARIKACE ™ 32 SURFAXIN r 32 Pseudomonas aeruginosa infections 32 Participation Deadline 32 haematologic 32 worrisome 32 RGB # 32 subclinical cardiovascular disease 32 European Medicines Evaluation 32 efficacy tolerability 32 Synavive 32 oral anticoagulants 32 MOZOBIL 32 Ducrozet 32 epidural steroids 32 JP-#/fipamezole 32 survival positionings 32 vidofludimus 32 BioNumerik 32 multiple sclerosis rheumatoid arthritis 32 conflicting casualty tolls 32 pancreatic acinar cell 32 Rezonic 32 Soliris therapy 32 Torsades de Pointes 32 ENTEREG ® 32 Visian Toric ICL 32 ragweed allergic children 32 Merck KGaA Erbitux 32 lymphomas leukemias 32 tanespimycin 32 EGFR mutation positive 32 tantalizing hints 32 neovascular diseases 32 topical anti infectives 32 ELND# 32 therapeutic armamentarium 32 Reni Benjamin 32 Amgen Prolia 32 Hedgehog antagonist 32 clearest indication yet 32 targets VEGFR EGFR 32 Spokesman Satoshi Fukuoka 32 COMFORT II 32 Phase #/#a trial 32 dirucotide 32 oncologic diseases 32 recombinant interferon 32 endothelin antagonist 32 fuel Sajjil 32 Enam Securities economist Sachchidanand 32 mTOR inhibitors 32 Our PriceWatch Alerts 32 cardioprotection 32 Precautionary X rays 32 vismodegib 32 pharmacodynamic 32 thetreatment 32 leukaemias 32 nabilone 32 hematologic malignancies 32 neurocognitive deficits 32 PASI scores 32 cautiously envisaging 32 iii Cubist 32 Corlux 32 farletuzumab 32 hinted 32 spinal manipulative 32 tuberculosis TB sepsis 32 oral antiviral 32 cardiovascular ischemic 32 evils Ghani 32 REMUNE R 32 bone sarcomas 32 progressive multifocal 32 BEMA Buprenorphine 32 mutated EGFR 32 ASG 5ME 32 Conflicting signals 32 OMP designation 32 tumor necrosis 32 airspeed readings 32 corneal wound 32 surrogate markers 32 ocrelizumab 32 epidemiologic studies 32 glimmers 32 ThGRF 32 injectable formulations 32 randomized Phase 2b 32 eculizumab therapy 32 PFO closure 32 CONBRIZA 32 catheter occlusion 32 virus HBV infection 32 lateral extents 32 clinical trials SGN 32 Alvise Marino 32 Cephalon Oncology 32 includes TOLAMBA TM 32 PI3K inhibitors 32 ADAGIO study 32 reversing heparin 32 velafermin 32 BLA filing 32 Mr Koukoulas 32 Ominous signs 32 ProSavin 32 ZACTIMA